title: Ebolavirus vaccines for humans and apes.
abstract: Because of high case fatality proportions, person-to-person transmission, and potential use in bioterrorism, the development of a vaccine against ebolavirus remains a top priority. Although no licensed vaccine or treatment against ebolavirus is currently available, progress in preclinical testing of countermeasures has been made. Here, we will review ebolavirus vaccine candidates and considerations for their use in humans and wild apes.
authors.affiliation: VRC/NIAID/NIH, 40 Convent Drive, Bethesda, MD 20892, USA.
authors.forename: Hugues
authors.initials: H
authors.lastname: Fausther-Bovendo
authors.forename: Sabue
authors.initials: S
authors.lastname: Mulangu
authors.forename: Nancy J
authors.initials: NJ
authors.lastname: Sullivan
mesh_terms: D000818:Animals; D035843:Biomedical Research / Q000639:trends; D046129:Ebola Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D029043:Ebolavirus / Q000276:immunology*; D019142:Hemorrhagic Fever, Ebola / Q000453:epidemiology / Q000517:prevention & control* / Q000662:veterinary*; D015186:Hominidae; D006801:Humans; D014611:Vaccination / Q000379:methods*
chemical_list: D046129:Ebola Vaccines